Post Tagged with: "rheumatoid arthritis (RA)"

Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis

Rheumatology August 1, 2017 at 8:23 AM 0 comments

*Bruno Sarmento,1,2 Marco Sarmento3,4 1. Instituto de Investigação e Inovação em Saúde (i3S) and Instituto de Engenharia Biomédica (INEB), Universidade do Porto, Porto, Portugal 2. Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde (CESPU) Instituto Universitário de Ciências da Saúde, Porto, Portugal 3. Faculdade de Medicina Universidade deRead More

The ‘Nucleolus’ Hypothesis of Autoimmune Diseases and Its Implications

The ‘Nucleolus’ Hypothesis of Autoimmune Diseases and Its Implications

*Wesley H. Brooks,1 Yves Renaudineau2,3 1. Department of Chemistry, University of South Florida, Tampa, Florida, USA 2. INSERM ESPRI, ERI29/EA2216, LabEx IGO “Immunotherapy Graft Oncology”, Réseau épigénétique et réseau canaux ioniques du Cancéropole Grand Ouest, European University of Brittany, Brest, France 3. Laboratory of Immunology and Immunotherapy, Brest University Medical SchoolRead More

The Evolving Biosimilar Landscape: Approval of the First Etanercept Biosimilar in Europe, An Interview With Emilio Martín-Mola

The Evolving Biosimilar Landscape: Approval of the First Etanercept Biosimilar in Europe, An Interview With Emilio Martín-Mola

European Medical Journal August 23, 2016 at 8:21 AM 0 comments

*Caroline Charles Scilink Medical Writing, Biarritz, France. *Correspondence to scilink.mw@gmail.com Disclosure: Professor Martín-Mola has received funding from Biogen, Roche, MSD, UCB, and Sanofi. Support: Biogen provided funding for medical writing support in the development of this article. Biogen reviewed the article for medical accuracy and provided feedback to the authors.Read More

Pregnancy in Chronic Arthritis: Only a Matter of Planning

Pregnancy in Chronic Arthritis: Only a Matter of Planning

Rheumatology July 28, 2015 at 9:32 AM 0 comments

*Paloma Vela Sección de Reumatología, Hospital General Universitario de Alicante; Departamento de Medicina, Universidad Miguel Hernández de Elche, Alicante, Spain *Correspondence to palomavela62@gmail.com Disclosure: The author has received support for assistance to scientific meetings from AbbVie, Pfizer, and Roche; honoraria for consulting and delivering of presentations from AbbVie, BMS, MSD,Read More